A double blind, controlled, randomised, clinical study to assess the safety of Repevax administered one month after Revaxis or placebo to healthy adults

Trial Profile

A double blind, controlled, randomised, clinical study to assess the safety of Repevax administered one month after Revaxis or placebo to healthy adults

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Sep 2017

At a glance

  • Drugs DT-poliovirus vaccine (Primary) ; DTaP poliovirus vaccine (Primary)
  • Indications Diphtheria; Pertussis; Poliomyelitis; Tetanus
  • Focus Adverse reactions
  • Sponsors sanofi pasteur MSD
  • Most Recent Events

    • 08 Apr 2009 Additional lead trial investigator Anne Fiquet reported by ClinicalTrials.gov.
    • 27 Oct 2007 Status changed from in progress to completed.
    • 18 Jan 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top